A number of experimental observations suggest that the proto-oncogene c-ab1 participates in the regulation of hematopoietic cell growth. We used an antisense strategy t o study the relationship between c-ab1 expression and hematopoietic cell proliferation and differentiation. Purified normal human bone marrow-derived CD34+ cells were obtained by immunomagnetic selection and incubated with 18-base-unmodified antisense oligodeoxynucleotides complementary t o t h e first six codons of the two alternative first exons of c-&l, la and lb. At the end of incubation, an aliquot of cells was assayed for clonogenic growth and the remainder was used for flow cytometric analyses. Cell kinetics were evaluated by means of both single parameter DNA and bivariate DNA/bromodeoxyuridine (BrdU) flow cytometry. Apoptosis was routinely studied by DNA flow cytometric analysis and, in some cases, also through DNA agarose gel electrophoresis for detection of oligonucleosomal DNA fragments. Expression of differentiation markers was studied by flow cytometry. Exposure t o antisense oligonucleotides specifically inhibited the accumulation of c-ab1 mRNA in CD34' cells. Preincubation with the c-ab1 antisense oligomers reduced the proportion of cells in S-phase from 19% HE C-ABL PROTO-ONCOGENE encodes for a nonreceptor tyrosine kinase, ~145""~', whose biologic function is still unknown.' The protein is ubiquitously expressed and is mainly localized in the nucleus, although it may also be found in the cytoplasm.* Recent results from biochemical and molecular studies have indicated that c-ab1 may be involved in cell cycle regulation.' The carboxy-terminal portion of c-ab1 contains two distinct domains that can bind to Factin' and to DNA,4 respectively. The c-ab1 protein becomes hyperphosphorylated during metaphase, resulting in an inhibition of its DNA-binding activity! More recently, it has been found that c-ab1 and the retinoblastoma gene protein form a complex in vitro, and that this complex regulates the cell cycle-related activity of ~-a b l .~ Taken together, these data suggest a role for c-ab1 in signal transduction as well as in cell-cycle regulation.'
A number of experimental observations suggest that the proto-oncogene c-ab1 participates in the regulation of hematopoietic cell growth. We used an antisense strategy t o study the relationship between c-ab1 expression and hematopoietic cell proliferation and differentiation. Purified normal human bone marrow-derived CD34+ cells were obtained by immunomagnetic selection and incubated with 18-base-unmodified antisense oligodeoxynucleotides complementary t o t h e first six codons of the two alternative first exons of c-&l, la and lb. At the end of incubation, an aliquot of cells was assayed for clonogenic growth and the remainder was used for flow cytometric analyses. Cell kinetics were evaluated by means of both single parameter DNA and bivariate DNA/bromodeoxyuridine (BrdU) flow cytometry. Apoptosis was routinely studied by DNA flow cytometric analysis and, in some cases, also through DNA agarose gel electrophoresis for detection of oligonucleosomal DNA fragments. Expression of differentiation markers was studied by flow cytometry. Exposure t o antisense oligonucleotides specifically inhibited the accumulation of c-ab1 mRNA in CD34' cells. Preincubation with the c-ab1 antisense oligomers reduced the proportion of cells in S-phase from 19% HE C-ABL PROTO-ONCOGENE encodes for a nonreceptor tyrosine kinase, ~145""~', whose biologic function is still unknown.' The protein is ubiquitously expressed and is mainly localized in the nucleus, although it may also be found in the cytoplasm.* Recent results from biochemical and molecular studies have indicated that c-ab1 may be involved in cell cycle regulation.' The carboxy-terminal portion of c-ab1 contains two distinct domains that can bind to Factin' and to DNA,4 respectively. The c-ab1 protein becomes hyperphosphorylated during metaphase, resulting in an inhibition of its DNA-binding activity! More recently, it has been found that c-ab1 and the retinoblastoma gene protein form a complex in vitro, and that this complex regulates the cell cycle-related activity of ~-a b l .~ Taken together, these data suggest a role for c-ab1 in signal transduction as well as in cell-cycle regulation. ' The biologic role of c-ab1 in normal hematopoiesis is unclear. Studies based on the use of antisense oligomers have shown that c-ab1 function is important for the in vitro proliferation and differentiation of granulocyte-macrophage colony-forming units (CFU-GM).6,7 Animal models have provided little information so far regarding the role of c-ab1 in hematopoietic cell proliferation and differentiation.','
In this work we used an antisense strategy to study the relationship between c-ab1 expression and proliferation of normal human bone marrow (BM)-derived CD34+ cells.
f 5% (mean f SD) t o 7% f 4% ( P < .05), and BrdU labeling from 13% f 6% t o 6% f 3% (P < .05). Flow cytometry and DNA agarose gel electrophoresis showed that treated CD34' cells accumulated in the Go/G1 region of the DNA histogram with no evidence of either differentiation or apoptosis. By contrast, both growth factor deprivation and exposure of CD34+ cells to the tyrosine kinase inhibitor tyrphostin AG82 clearly induced apoptosis. When cells were preincubated with antisense oligonucleotides and then plated for evaluation of colony formation, this resulted in a significant inhibition of colony forming unit granulocyte-macrophage growth (from 44 f 15 t o 22 k 9; P < .01) but had no effect on burstforming unit erythroid growth (24 f 11 v21 k 11; P < .05).
These results suggest that c-ab1 expression is critical for entry of human CD34+ hematopoietic cells into S-phase and for their differentiation t o granulocyte-macrophage progenitors. They also indicate that other tyrosine kinases besides p145c-"b' are active in the prevention of apoptosis, so that inhibition of c-ab1 RNA accumulation arrests CD34' cells in Go/G, without activating programmed death.
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30 minutes at 400g; interface.cells were washed three times and resuspended at 2 X 106/mL in Iscove's modified Dulbecco's medium (IMDM; Irvine Scientific, Santa Ana, CA) with 20% fetal bovine serum (FBS; HyClone, Logan, UT). Adherent cell depletion was obtained by incubation in 25-cm2 tissue culture flasks for two sequential l-hour periods at 37"C, 5% COz. LDBMCs depleted of adherent cells (LDBMCs AC-) were further depleted of T lymphocytes (LDBMCs AC-T-) by rosetting with sheep red blood cells pretreated with 2-aminoethylisothiouronium bromide. LDBMCs ROSTI ET AL QBEND 10 MoAb directed against the CD34 antigen (Immunotech). LDBMCs AC-T-CD1 9-were incubated with the anti-CD34 immunobeads at a ratio of I mg of beads per IO' LDBMCs AC-T-CD19-for 15 minutes at 4°C. Cells were then exposed to a cobaltsamarium magnet for 10 minutes at room temperature and the nonadherent fraction was discarded. Bead-conjugated cells were recovered, washed, and evaluated for their purity by flow cytometry using a fluorescein isothiocyanate (F1TC)-conjugated anti-HPCA-2 CD34 MoAb (clone 8G12; Becton Dickinson, San Jose, CA). The percentage of CD34' cells was greater than 90% in all experiments.
Oligodeoxynucleotides. Synthetic nonmodified oligodeoxynucleotides were purchased from Med Probe (Med Probe, Oslo, Norway). Four types of oligomers were used: ( l ) 18-base antisense oligodeoxynucleotides complementary to either the 6.0 kb (exon Ia) or 7.0 kb (exon Ib) c-ab1 mRNA, beginning from the second codon of each mRNA (the sequences are 5'-CTTCAGGCAGATCTCCAA-3' and 5'-TTJTCCAGGCTGCTGCCC-3', respectively) and (2) 18-base sense oligodeoxynucleotides, corresponding to the Ia and Ib antisense sequences and used as control (the sequences are 5'-7TGGAGATCTGCCTGAAG-3' and 5'GGGCAGCAGCCTGGA-AAA-3', respectively).
Pre-incubafion with oligomers. CD34' cells (lo5) were incubated with both anti Ia and anti Ib oligomers for 17 to 20 hours at 37°C in liquid culture (IMDM with 10% FBS). The final concentration for each oligomer was 14 pmol/L, which had proven to be optimal in previous ~tudies.~ Control cultures were performed both with sense oligomers and with culture medium only. At the end of the incubation, an aliquot of the CD34' cells was used for the clonogenic assay and the remainder was used for the flow cytometric analysis (see below). In the experiments in which bromodeoxyuridine (BrdU) incorporation was evaluated, 30 minutes before the end of preincubation CD34' cells were pulse-labeled with 30 pmol/L BrdU (Sigma Chemical CO, St Louis, MO); the medium was then washed out and the cells were rinsed twice with fresh medium before fixing with cold 70% ethanol. When preincubation with oligomers was protracted for 48 to 72 hours (according to cell availability), the appropriate oligomers were added to the culture medium at a concentration of 7 pmol/L every 24 hours.
In some experiments, CD34+ cells were preincubated with the tyrosine kinase inhibitor tyrphostyn AG82 at a concentration of 200 pmol/L for 24 hours, washed three times, and evaluated by DNA electrophoresis and flow cytometric DNA analysis to detect apoptosis as previously described in detail."
Reverse transcription polymerase chain reaction (RT-PCR) analysis of c-ab1 mRNA. To evaluate the effects of oligonucleotides on cab1 mRNA expression, total RNA was isolated according to standard procedures" from 2 to 4 X lo4 CD34' cells after a 20-hour treatment with the oligonucleotides and from control CD34' cells and analyzed by a competitive RT-PCR in which c-ah1 and p-actin cDNAs were simultaneously amplified. Briefly, total RNA was reverse transcribed in a final volume of 20 pL using 250 ng each of c-ab1 and p-actin 3' antisense primers complementary to the third exon of c-abl', and to nucleotides 1,032 to 1,055 of the p-actin c-DNA." The reaction mixture contained: 100 U of Moloney-murine leukemia virus reverse transcriptase (GIBCO-BRL, Gaithersburg, MD), 20 U RNasin, 0.2 mg/rnL bovine serum albumin (Promega Biotec, Madison, Wl), 0.01 m o w dithiothreitol (D'IT), 50 mmol/L TRIS-HCI, pH 8.3.75 mmol/ L KCI, 3.0 mmoVL MgCI, and 2.5 mmol/L deoxynucleotide triphosphates (dNTPs). RNA and primers were initially heated for 3 minutes at 80°C followed by 30 minutes at 69°C. After addition of the enzyme, the reaction mixture was incubated for 60 minutes at 42°C and 10 minutes at 95°C. Ten microliters of cDNAs as subsequently amplified in a final volume of 50 pL containing 125 ng of the two 3' primers used in the reverse transcription reaction and 250 ng each of the 5' sense primers corresponding to the second exon of c-abl" and to nucleotides 819 to 842 of the p-actin cDNA." Amplification was performed in 50 mmol/L KC], 10 mmol/L TRIS-HC1, pH 8.3, I .5 mmol/L MgCI,, 0.01% gelatin, 0.4 mmol/L dNTPs and 1 U of Taq polymerase (Perkin-Elmer, Branchburg, NJ). After denaturation for 2 minutes at 94"C, samples underwent 40 cycles of amplification involving 1 minute at 94°C 25 seconds at 61°C and 2 minutes at 72°C. In the final cycle, temperature was held at 72°C for 7 minutes. Amplification products were run through a 2% agarose gel in I X TBE buffer. The 0-actin PCR product was directly visualized on the ethidium bromide-stained gel. Because the c-ab1 gene is much less expressed than the p-actin gene, its evaluation after simultaneous c-ab1 and @-actin RT-PCR required the gel to be Southern blotted onto a nylon filter that was hybridized with a "P-labeled probe spanning the second and the third exons of c-abl.
Colony assays. Clonogenic assays were performed as previously described.' Briefly, 5 X IO3 CD34' cells were plated in 35-mm Petri dishes in 1 mL aliquots of IMDM containing 30% FBS, 5 X M 2-mercaptoethanol, 2 IU erythropoietin, 10 ng interleukin-3, 10 ng granulocyte-macrophage colony-stimulating factor and 0.9% (wt/ vol) methylcellulose. Assays were performed in duplicate. After incubation for 14 days at 37°C in a fully humidified atmosphere supplemented with 5% COz. the number of colonies was scored using an inverted microscope.
Flow cytometric analysis of cell-cycle phase distribution and BrdU uptake. Monoparametric conventional cell-cycle analysis was performed on control and treated nuclei using a Partec PAS I1 flow cytometer (Partec SPA, Basel, Switzerland). After preincubation with oligomers, ethanol-fixed cells were centrifuged, washed, and stained (30 minutes at room temperature) with 50 pg/mL propidium iodide (PI) (Calbiochem, San Diego, CA) in phosphate-buffered saline (PBS). The staining solution also contained 0. l % Triton X 1 0 0 (Calbiochem) and 1% wt/vol RNAse A (Sigma).'4 The percentage frequencies of cells in the different cell-cycle phases were calculated using a mathematical model adapted for a dedicated Partec computer."
The presence of apoptotic cells was also investigated with the same analysis, according to the principle that the reduced stainability of apoptotic cells with DNA fluorochromes is a consequence of partial loss of low-molecular-weight DNA.'"I7
For biparametric BrdUlDNA analysis, after a pulse-label with 30 ymol/L BrdU, CD34' cells were washed and fixed with ice-cold 70% ethanol. Then cells were washed with PBS and DNA was denaturated with 2 N HCI (20 minutes at room temperature). BrdU uptake was detected after 30-minute incubation with 100 pL of a 1 : 10 dilution in PBS of anti-BrdU mouse MoAb (Becton Dickinson, San Jose, CA), followed by incubation with 100 pL of a 1 5 0 dilution in PBS of a FITC-labeled goat antimouse MoAb (Sigma). Finally, cells were washed twice with PBS at room temperature and counterstained for 3 hours at room temperature with 5 pg/mL PI."
Bivariate measurement of green fluorescence (BrdU-labeled cells) versus red fluorescence (DNA content) was performed with a FACStar Plus flow cytometer (Becton Dickinson, San Jose, CA) as previously described."
Gel electrophoresis for detection of oligonucleosornal DNA fragments. DNA fragmentation was evaluated by DNA electrophoresis on 2% agarose gel as previously described.'"
Immunophenotyping. Fluorescence-activated cell sorting (FACS) analysis of differentiation markers was performed on purified CD34' cells after incubation for 20 hours in liquid culture (IMDM with 10% FBS) without (control) and with anti-ab1 oligonucleotides.
The expression of lineage-associated antigens on CD34' cells was determined by incubation with antibody against CD34 together with antibody to the specific antigen. Briefly, cells were incubated for 30 minutes at 4°C with a phycoerythrin-conjugated CD34 MoAb (anti-HPCA-2, clone 8G12) alone or with one of the following F I X - and the Student's t-test for paired data was used to verify the probability of significant differences between means.
RESULTS
We first evaluated the effect of anti-ab1 oligodeoxynucleotides on c-ab1 RNA accumulation in CD34' cells using a RT-PCR approach. The effect on CD34' cell proliferation and differentiation was then studied using four different approaches that all give different information: (1) in vitro committed progenitor cell growth was studied using classical 14-day semisolid methylcellulose cultures; (2) direct cell kinetics were evaluated by means of single parameter DNA and bivariate DNA/BrdU flow cytometric analyses; (3) apoptosis was investigated by both DNA flow cytometric analysis and gel electrophoresis for detection of oligonucleosoma1 DNA fragments; (4) differentiation was assessed by FACS analysis of lineage-associated antigens.
Inhibition of c-ab1 mRNA accumulation by antisense oligodeoxynucleotides. The aim of antisense strategy is to inhibit gene expression. The binding of an antisense oligonucleotide to its complementary portion of the mRNA molecule may result in either degradation of mRNA through RNAse H or inhibition of translation without altering RNA stability.2" To evaluate whether the antisense oligomers used provided specific gene inhibition, total cellular RNA from dif-3389 ferently treated samples was reverse transcribed and amplified using primers specific for sequences derived from the c-ab1 and P-actin genes. The two sequences were simultaneously amplified in the same reaction tube. A representative experiment involving control cells and cells exposed to antisense and sense oligomers, respectively, is illustrated in Fig  I . The similar level of the P-actin amplification product in different samples indicates that equal amounts of total RNA were used for amplification: in turn, this implies that the reduction of c-ab1 levels in the antisense-treated samples was caused by specific inhibition of c-ab1 mRNA expression. This is in agreement with previous observations that oligomers targeted against the two c-ab1 mRNAs induce RNA degradation and are effective in inhibiting the expression of Effect of oliRodeoxynucleotides on in vitro CD34' cell proliferation and differentiation in 14-day semisolid methylcellulose cultures. Results of studies on the clonogenic growth of CD34' cells are summarized in Table I . After 14 days, approximately 50 to 100 colonies were obtained from 5 X IO' control CD34' cells plated under the experimental conditions previously described. About two thirds were CFU-GM and one third erythroid burst forming units (BFU-E) (Table l) .
When CD34' cells were exposed to sense oligomers, the number of CFU-GM-and BFU-E-derived colonies did not differ from that of control cultures. Preincubation with the antisense oligomers significantly inhibited CFU-GM (P < .Ol) but had no effect on BFU-E growth. In most of the samples exposed to antisense oligomers, not only the number but also the size of CFU-GM was reduced.
Cell-cycle studies. Results of both single parameter DNA and bivariate DNA/BrdU flow cytometric analyses are shown in Table 2 and in Fig 2. The majority of fresh CD34' cells isolated from normal human BM was in the quiescent state. In fact, evaluation of nuclear DNA content by staining with PI showed that 12% ? 3% of cells were in S-phase. Incubation for 17 to 20 hours in liquid culture (IMDM with 10% FBS) induced recruitment of cells into the cell cycle; as shown in Table 2 , the percentage of cells in S-phase increased to 19% ? 5%, whereas BrdU uptake (BrdU labeling index) was 12% ? 6%.
Treatment with antisense oligomers resulted in a signifip I 45c.ah'? cant decrease in both DNA S-phase and BrdU uptake with respect to the control, whereas no effect was observed when sense oligomers were used ( Table 2) . After exposure to antisense oligomers, there was an accumulation of cells in the Go-GI region of the DNA histogram (Fig 2) with no evidence of arrest during S-phase: in fact, the bivariate cytogram DNNBrdU failed to show significant aliquots of cells with a DNA content typical of the S-phase (Fig 2, window a) , but not incorporating BrdU (Fig 2, window b) . This indicates that entry into S-phase was inhibited. When antisense treatment was prolonged for 48 or 72 hours, no additional significant changes in the S-phase of CD34' cells were observed (data not shown).
Evaluation of apoptosis in CD34' cells following exposure to anti-ah1 oligonucleotides and the tyrosine kinase inhibitor tyrphostyn AG82. We then explored the possibility that inhibition of S-phase entry resulted in the apoptosis of CD34' cells. The presence of apoptosis was established according to DNA electrophoresis and flow cytometry."' In several experiments in which CD34' cells were exposed ROSTI ET AL to antisense oligomers for up to 72 hours, no evidence of oligonucleosomal-size fragments was found on DNA electrophoresis, nor was there any sign of an apparently hypodiploid cell population on DNA flow cytometry.
To learn whether this simply reflected methodologic problems. we used established procedures for apoptosis induction."' First, growth factor deprivation using serum-free cultures induced apoptosis in CD34' cells (data not shown). Second, we used the tyrosine kinase inhibitor tyrphostin AG82, which induces apoptosis in hematopoietic cells and thereby reduces the fraction of cells in the S-phase of the cell cycle."' When CD34' cells were incubated for 24 hours in the presence of tyrphostin AG82 at a final concentration of 200 pmol/L, clear evidence of apoptosis was found (Fig  3) . This was indicated by the appearance of both DNA degradation on agarose gel electrophoresis and an apparently hypodiploid region, the A" peak, below the Go/GI region on DNA flow cytometry.
Effect qf anti-ah1 oligonucleotides on the immunophenov p e qf CD34' hematopoietic cells. The immunophenotype of BM CD34' cells is shown in Table 3 . There was no substantial difference between control cells and cells exposed to antisense oligomers with respect to the expression of lineage-associated antigens. In particular, there was no significant change in the proportion of CD34' cells expressing CD33.
DISCUSSION
Our present knowledge of c-ab1 function derives directly from studies of the normal gene and indirectly from investigations on constitutively activated genes, eg, bcr-ab1 fusion genes and v-abl.
Overexpression of c-ab1 has been found to inhibit in vitro growth of fibroblasts by causing cell-cycle arrest," suggesting that c-ab1 acts as a negative regulator of cell growth. By contrast, oligodeoxynucleotides antisense to c-ab1 have been shown to inhibit myeloid colony formation in vitro.".' Tybulewicz et alx and Schwartzberg et al" investigated c-ab1 function by examining the phenotypes of mice with homozygous disruption of the gene. These animals had no detectable c-ab1 protein and were severely affected, displaying increased perinatal mortality and multiple and variable phenotypes. Most animals had thymus and spleen atrophy, lymphopenia, foreshortened heads and eye defects. These findings are not consistent with the negative role of c-ab1 suggested by Sawyers et al"; this discrepancy, however, may reflect a cell-type dependent modulation of c-ab1 function, with the ab1 tyrosine kinase stimulating or inhibiting growth depending on the cell context.
Studies on bcr/abl transgenic mice or mice transplanted with hematopoietic cells infected with bcr/abl retroviruses have shown that these animals develop several hematologic malignancies, ranging from a myeloproliferative syndrome to acute myeloid or lymphoid leukemia.""" Abrogation of growth factor-dependence has been observed in murine and human myeloid cell lines after introduction and expression of the p2 IOkr'"h ' However, studies on fresh murine multipotent cells'" have provided more subtle results. When multipotent progenitor cells were infected with a retrovirus that carried bcr-abl. the mixed colonies that resulted were responsive to growth factors and could differentiate; these cells later became growth-factor independent but were not leukemogenic.'" A decreased rate of programmed cell death has been observed in Philadelphia-positive cells expressing the bcr-ab1 fusion protein.""."' Taken together, these observations suggest that the presence of bcr-ab1 alone does not cause growth factor independence. although it initiates a stepwise process."'
In the present work, inhibition of c-ab1 mRNA expression resulted in growth arrest of CD34' cells, as indicated by the reduced fraction of cells actively synthesizing DNA ( Sphase) and the higher proportion in G&,. Growth arrest may have different outcomes, including entry into Go reversibility or quiescence, programmed cell death and differentiation. CD34' cells treated with c-ab1 antisense oligonucleotides for 24 to 72 hours apparently did not undergo apoptosis. After inhibition of all tyrosine kinases with tyrphostin AG82, the appearance of both the typical DNA degradation on agarose gel electrophoresis and the A,, peak on DNA flow cytometry (Fig 3) clearly indicated the presence of apoptotic cells. Therefore, hematopoietic progenitor cells contain tyrosine kinases other than p14S""h' that are active in preventing apoptosis, and inhibition of p14S''"h' production alone does not allow cells to proceed to programmed cell death.
Induction of differentiation was also a very unlikely outcome of growth arrest. In fact, the expression of lineageassociated markers such as CD33 was not modified after exposure to anti-ab1 oligonucleotides ( Table 3) . CD34 
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ROSTl ET AL that lack CD33 are considered to be more primitive hematopoietic cells that are precursors to clonogenic cells, whereas CD34+ cells expressing CD33 have been shown to be committed If growth arrest induced differentiation in CD34+ hematopoietic cells, the number of CD33' committed progenitors would be expected to increase; the lack of any change in the proportion of CD33' cells indicates that this was not the case. This was indirectly confirmed also by the observation that the number of CFU-GM decreased after exposure to antisense oligomers.
Our results suggest that c-ab1 function is critical for entry of CD34+ hematopoietic cells into the S-phase of the cell cycle. The kinetic data reported in Table 2 and Fig 2 are consistent with the hypothesis that ~1 4 5 " "~' plays a specific role in the transition of cells from G o G I to S phase. They are in agreement with the observation that c-ab1 activates c-myc tran~cription'~ and that this effect might be cell lineage-or tissue-specific.'s The different effect of anti-ab1 oligonucleotides on CFU-GM and BFU-E growth might be explained by a different induction of c-myc mRNA by p 14Yab' in granulocyte-macrophage versus erythroid progenitors.
These findings may be helpful in understanding the pathogenesis of chronic myelogenous leukemia (CML) and may provide a potentially useful tool for ex vivo cell manipulation. CML is a condition with an activated c-ab1 proto-oncogene whose product, p210b"""h', has markedly increased tyrosine kinase activity, and a residual normal c-ab1 gene." Because tyrosine kinase activity is essential for the stimulation of cell growth by oncogenic ab1 proteins,' it can be speculated that p210kr-"" very actively induces entry into S phase of CML immature hematopoietic progenitors, a higher proportion of which, therefore, are cycling." This involves a greater likelihood of genetic errors whose frequency is directly related to the number of cell divisions.38 Therefore, CML stem cells are more likely to develop those genetic lesions that afford them growth factor independence and an aberrant differentiation profile; this would lead to acceleration and blast crisis.
